What is the difference between Opdivo and Keytruda?
Opdivo (nivolumab) and Keytruda (pembrolizumab) are two immunotherapy drugs used to treat various cancers. Both are monoclonal antibodies, known as PD1 inhibitors, first approved in 2014. Opdivo is from Bristol Myers Squibb, and Keytruda is from Merck & Co.
The main differences lie in their dosing, what other treatments they are recommended with, and what cancers they are approved to treat.
Opdivo Vs Keytruda Dosing Frequency
Opdivo: Given via IV infusion over 30 minutes every 2 to 4 weeks depending on the cancer you have.
Opdivo Qvantig: This is a new formulation of Opdivo that contains hyaluronidase that allows it to be given subcutaneously (under the skin) over 3 to 5 minutes every 2, 3, or 4 weeks depending on the dose and the cancer you have (see Opdivo Vs Opdivo Qvantig: What is the difference?).
Keytruda: Given via IV infusion over 30 minutes every 3-6 weeks.
Opdivo Vs Keytruda Combination Therapy
Opdivo Combination Treatment
Depending on the cancer being treated, Opdivo is used in combination with:
Opdivo Qvantig shares solid tumor FDA approvals with Opdivo, but it is not approved for use in classical Hodgkin lymphoma (cHL), malignant pleural mesothelioma, or in children. It is also not approved for use in combination with Yervoy, but is approved for use with Cabometyx or chemotherapy.
Keytruda Combination Treatment
Depending on the cancer being treated, Keytruda is used in combination with:
- Pemetrexed (Alimta) and platinum chemotherapy
- Carboplatin (Paraplatin) and either paclitaxel or paclitaxel protein-bound (Abraxane)
- Platinum and flurouracil
- Trastuzumab (Herceptin) plus fluoropyrimidine- and platinum-containing chemotherapy
- Axitinib (Inlyta)
- Lenvatinib (Lenvima)
- Chemotherapy.
Both drugs are also used alongside fluoropyrimidine- and platinum-containing chemotherapy for treating certain gastric cancers.
Related questions
- What is the success rate of Keytruda?
- How long does it take for Keytruda to work?
- What are monoclonal antibodies?
Opdivo Vs Keytruda Approved Uses
Keytruda is approved for additional cancer types, including non-small cell lung cancer (as a first-line treatment), cervical cancer, Merkel cell carcinoma, Primary mediastinal large B-cell lymphoma, endometrial carcinoma, biliary tract cancer, tumor mutational burden-high cancer, and triple-negative breast cancer.
Opdivo was the first for adjuvant treatment of high-risk urothelial carcinoma, and is also used for pleural mesothelioma (cancer that affects the lining of the lungs and chest wall), and colorectal cancer.
Both are used for various other cancers, including:
- skin cancers
- lung cancer
- kidney cancer
- classical Hodgkin lymphoma
- cancer of the stomach and esophagus
- squamous cell cancer
- bladder cancer
- liver cancer.
*There are slight differences in approval specifics between Opdivo and Keytruda, such as if they are approved first-line or just for advanced (metastatic) cancer.
Opdivo Qvantig is only approved for:
- Melanoma
- Bladder cancer (urothelial carcinoma)
- Colorectal cancer
- Gastric cancer, gastroesophageal junction cancer, and esophageal cancer
- Kidney cancer (renal cell carcinoma)
- Liver cancer (hepatocellular carcinoma)
- Non-small cell lung cancer (NSCLC)
- Squamous cell cancer of the head and neck.
References
- Opdivo Prescribing Information. https://packageinserts.bms.com/pi/pi_opdivo.pdf
- Opdivo Qvantig Prescribing Information. https://packageinserts.bms.com/pi/pi_opdivo-qvantig.pdf
- Keytruda Prescribing Information. https://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_pi.pdf
Read next
How is Keytruda used for lung cancer?
Keytruda (pembrolizumab) is a type of immunotherapy that has significantly changed the treatment landscape for lung cancer, especially non-small cell lung cancer (NSCLC). It works by helping the immune system recognize and attack cancer cells more effectively, mainly by blocking the PD-1 pathway that tumors use to evade immune detection.
Continue reading
How effective Is Keytruda for metastatic melanoma?
Keytruda (pembrolizumab) is an immunotherapy known as a PD-1 inhibitor, approved by the FDA for the treatment of unresectable or metastatic melanoma. This therapy has transformed the outlook for many patients with advanced melanoma, offering the potential for extended survival and durable responses in some cases. At 10 years, 34% of patients treated with Keytruda were still alive, compared to 23.6% for those treated with ipilimumab, another immunotherapy.
Continue reading
When is Keytruda used for prostate cancer?
Keytruda (pembrolizumab) is used only for advanced prostate cancer with specific genetic features: microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) tumors. This immunotherapy is not a standard prostate cancer treatment but is reserved for biomarker-confirmed cases where other options have failed.
Continue readingSee also:
Aimovig
Learn about Aimovig (erenumab-aooe) a once-monthly, injectable medication that can be ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Nurtec ODT
Nurtec ODT (rimegepant) is used to treat acute migraines and prevent episodic migraines, by ...
Emgality
Emgality (galcanezumab-gnlm) is a CGRP antagonist for the preventive treatment of migraine and for ...
Inderal
Inderal (propranolol) is used to treat angina, high blood pressure and heart rhythm disorders ...
Ajovy
Ajovy (fremanezumab-vfrm) is a preventive migraine treatment. Includes Ajovy side effects ...
Vyepti
Vyepti (eptinezumab-jjmr) is used for the preventive treatment of migraine. Includes Vyepti ...
Botox Cosmetic
Botox Cosmetic is a prescription treatment for fine lines and wrinkles. It temporarily improves the ...
Fremanezumab
Fremanezumab is used for chronic migraine, headache, migraine, migraine prevention
Related medical questions
- Pembrolizumab vs. nivolumab: How do they compare?
- Can you take prednisone with Keytruda?
- Is Keytruda covered by Medicare / Medicaid?
- How are Inlyta and Keytruda used in kidney cancer?
- How is pembrolizumab (Keytruda) administered?
- Is lenvatinib / pembrolizumab used in endometrial cancer?
- Is Xalkori the same as Opdivo or Keytruda?
- What are biologic drugs and how do they work?
- How effective is Opdivo?
- How long does Opdivo take to work and how do you know if it's working?
- How long does Opdivo stay in your system?
- What happens when you stop taking Opdivo for melanoma?
- How effective are Opdivo and Yervoy when taken together?
- Opdivo vs Opdivo Qvantig: What is the Difference?
- Is Opdivo a chemotherapy or immunotherapy drug?
- How are Opdivo and Yervoy administered?
- Is Opdivo approved for treating bladder cancer?
Drug information
Related support groups
- Keytruda (22 questions, 63 members)
- Opdivo (18 questions, 53 members)
- Non-Small Cell Lung Cancer (53 questions, 73 members)
- Renal Cell Carcinoma (32 questions, 103 members)
- Melanoma (20 questions, 52 members)